SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form UPLOAD - SEC-generated letter:
SEC Accession No. 0000000000-22-006963
Filing Date
2022-06-29
Accepted
2022-06-29 14:30:05
Documents
2

Document Format Files

Seq Description Document Type Size
1 filename1.pdf LETTER 27511
2 filename2.txt TEXT-EXTRACT 1155
  Complete submission text file 0000000000-22-006963.txt   39801
Mailing Address 1359 BROADWAY, SUITE 1710 NEW YORK NY 10018
Business Address 1359 BROADWAY, SUITE 1710 NEW YORK NY 10018 (212) 433-3791
Zentalis Pharmaceuticals, Inc. (Filed for) CIK: 0001725160 (see all company filings)

IRS No.: 823607803 | Fiscal Year End: 1231
Type: UPLOAD
SIC: 2834 Pharmaceutical Preparations